In vivo magnetic resonance spectroscopy of gynaecological tumours at 3.0 Tesla

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 116, Issue 2, 2009, Pages 300-303

  Booth, S J ^a   Pickles, M D ^a   Turnbull, L W ^a  

^a UNIVERSITY OF HULL   (United Kingdom)

Author keywords

3.0 T; Gynaecological neoplasms; MRS

Indexed keywords

ARTICLE; FEMALE; GYNECOLOGIC CANCER; HISTOPATHOLOGY; HUMAN; IN VIVO STUDY; MAGNETIC FIELD; MAJOR CLINICAL STUDY; OVARY CANCER; PELVIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTON NUCLEAR MAGNETIC RESONANCE; TERTIARY HEALTH CARE; UTERINE CERVIX CANCER; UTERUS CANCER; VULVA CANCER;

CHOLINE; FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; LIPIDS; MAGNETIC RESONANCE SPECTROSCOPY; NEOPLASM RECURRENCE, LOCAL; OVARIAN NEOPLASMS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS; UTERINE NEOPLASMS; VULVAR NEOPLASMS;

EID: 57449084173     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2008.02007.x     Document Type: Article

References (7)

1. Gruetter R, Weisdorf SA, Rajanayagan V, Terpstra M, Merkle H, Truwit CL, et al. Resolution improvements in in-vivo 1H NMR spectra with increased magnetic field strength. J Magn Reson 1998 135 : 260 4.
2. Okada T, Harada M, Matsuzaki K, Nishitani H, Aono T. Evaluation of female intrapelvic tumors by clinical proton MR spectroscopy. J Magn Reson Imaging 2001 13 : 912 17.
3. Mountford C, Stanwell P, Ferrier A, Bourne R, Doran S, Christie J, et al. In vivo spectroscopy and imaging of the ovary in vivo at 3 tesla and spectroscopy on biopsy at 8.5 tesla. J Women's Imaging 2005 7 : 71 6.
4. Celik O, Sarac K, Hascalik S, Alkan A, Mizrak B, Yologlu S. Magnetic resonance spectroscopy features of uterine leiomyomas. Gynecol Obstet Invest 2004 58 : 194 201.
5. Allen JR, Prost RW, Griffith OW, Erickson SJ, Erickson BA. In vivo proton (H1) magnetic resonance spectroscopy for cervical carcinoma. Am J Clin Oncol 2001 24 : 522 9.
6. DeSouza NM, Soutter WP, Rustin G, Mahon MM, Jones B, Dina R, et al. Use of neoadjuvant chemotherapy prior to radical hysterectomy in cervical cancer: monitoring tumour shrinkage and molecular profile on magnetic resonance and assessment of 3-year outcome. Br J Cancer 2004 90 : 2326 31.
7. Mahon MM, Cox J, Dina R, Soutter WP, Mcindoe GA, Williams AD, et al. 1H Magnetic resonance spectroscopy of preinvasive and invasive cervical cancer: in vivo-ex vivo profiles and effect of tumour load. J Magn Reson Imaging 2004 19 : 356 64.